Revance Therapeutics (NASDAQ:RVNC) Coverage Initiated by Analysts at StockNews.com
StockNews.com began coverage on shares of Revance Therapeutics (NASDAQ:RVNC – Free Report) in a research report report published on Sunday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Several other brokerages have also recently issued reports on RVNC. Piper Sandler cut Revance Therapeutics from a “strong-buy” rating to a “hold” rating in […]
More Stories
OneDigital Investment Advisors LLC Buys 6,222 Shares of Vanguard Dividend Appreciation ETF (NYSEARCA:VIG)
OneDigital Investment Advisors LLC grew its holdings in shares of Vanguard Dividend Appreciation ETF (NYSEARCA:VIG – Free Report) by 6.1%...
Salesforce, Inc. (NYSE:CRM) is KBC Group NV’s 10th Largest Position
KBC Group NV increased its holdings in shares of Salesforce, Inc. (NYSE:CRM – Free Report) by 171.2% during the third...
reAlpha Tech (NASDAQ:AIRE) Issues Earnings Results
reAlpha Tech (NASDAQ:AIRE – Get Free Report) issued its quarterly earnings results on Tuesday. The company reported ($0.05) earnings per...
Planning Capital Management Corp Buys 660 Shares of UnitedHealth Group Incorporated (NYSE:UNH)
Planning Capital Management Corp raised its position in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 53.3% during the 3rd...
Vanguard Tax-Exempt Bond ETF (NYSEARCA:VTEB) Shares Sold by OneDigital Investment Advisors LLC
OneDigital Investment Advisors LLC lowered its holdings in Vanguard Tax-Exempt Bond ETF (NYSEARCA:VTEB – Free Report) by 2.8% during the...
OneDigital Investment Advisors LLC Decreases Stock Position in Vanguard Growth ETF (NYSEARCA:VUG)
OneDigital Investment Advisors LLC decreased its position in Vanguard Growth ETF (NYSEARCA:VUG – Free Report) by 2.0% in the 3rd...